A Look Into Healthcare Sector Value Stocks

The Meaning Behind Value Stocks

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

1. Exicure XCUR - P/E: 0.34
2. Spok Holdings SPOK - P/E: 8.57
3. Palisade Bio PALI - P/E: 1.67
4. Zymeworks ZYME - P/E: 3.05
5. Agile Therapeutics AGRX - P/E: 0.2

Exicure has reported Q2 earnings per share at $-0.68, which has increased by 2.86% compared to Q1, which was -0.7. Spok Holdings saw a decrease in earnings per share from 0.23 in Q2 to $0.22 now. Its most recent dividend yield is at 8.6%, which has decreased by 2.22% from 10.82% in the previous quarter.

Most recently, Palisade Bio reported earnings per share at $-0.49, whereas in Q2 earnings per share sat at $-0.53. Most recently, Zymeworks reported earnings per share at $-0.38, whereas in Q2 earnings per share sat at $-0.75. Agile Therapeutics's earnings per share for Q3 sits at $-1.47, whereas in Q2, they were at -3.1.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.